ALZ-801 (valiltramiprosate)
small molecule · Alzheon · APOE as stratifier
Current state
- Status
- Phase 3 — 0 active of 5 tracked studies
- Sponsor
- Alzheon
- Modality
- small molecule
- Mechanism
- amyloid oligomer inhibitor, APOE4/4
- Thesis
- APOE as stratifier
- Record checked
- Verified by a curator
- Last change
- no change event observed since tracking began
- Last reviewed
- (2 days ago)
Trials — 5
| NCT | Title | Phase | Status | Start | Primary completion | N | APOE-strat. |
|---|---|---|---|---|---|---|---|
| NCT04157712 | Multiple Ascending Dose Study of ALZ-801 | PHASE1 | COMPLETED | 48 | no | ||
| NCT04585347 | Single Dose Study of ALZ-801 Prototype Tablets | PHASE1 | COMPLETED | 12 | no | ||
| NCT04693520 | Biomarker Effects of ALZ-801 in APOE4 Carriers With Early Alzheimer's Disease | PHASE2 | COMPLETED | 84 | no | ||
| NCT04770220 | An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects | PHASE3 | COMPLETED | 325 | no | ||
| NCT06304883 | Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects | PHASE3 | TERMINATED | 163 | no |
Publications — 0
No linked publication. Nothing has been resolved to this therapeutic in Europe PMC or OpenAlex. Where nobody has checked the record yet, this usually means the identifier is used inconsistently in the literature rather than that no work exists.
Change history — 0
No changes detected for ALZ-801 (valiltramiprosate) as of the snapshot taken .
This is not the same as nothing having happened. The oldest source in this snapshot last succeeded (2 days ago), and registry and filing data lag the events they describe. See methodology.